Glia as targets for antidepressants: An involvement in glial cell line-derived neurotrophic factor

Japanese Journal of Neuropsychopharmacology

Volumn 27, Issue 5-6, 2007, Pages 173-179

  Hisaoka, Kazue ^a   Takebayashi, Minoru ^a  

^a NATIONAL HOSPITAL ORGANIZATION   (Japan)

Author keywords

Antidepressant; ERK; GDNF; Glia; Serotonin

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DESIPRAMINE; FLUOXETINE; FLUVOXAMINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; IMIPRAMINE; MIANSERIN; MILNACIPRAN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MONOAMINE; NORTRIPTYLINE; PAROXETINE; PROTEIN TYROSINE KINASE; REBOXETINE; SEROTONIN;

ALCOHOLISM; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BRAIN FUNCTION; CENTRAL NERVOUS SYSTEM DISEASE; CHRONIC PAIN; COGNITION; CONTROL GROUP; DEGENERATIVE DISEASE; DRUG DEPENDENCE; DRUG EFFICACY; DRUG MECHANISM; DRUG TARGETING; ENZYME ACTIVITY; GLIA; GLIA CELL; HUMAN; HUNTINGTON CHOREA; LEARNING; MEMORY; MOOD DISORDER; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PARKINSON DISEASE; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN SECRETION; REVIEW; SPINAL CORD INJURY; SYNAPTOGENESIS;

ANIMALS; ANTIDEPRESSIVE AGENTS; DRUG DESIGN; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HUMANS; MOOD DISORDERS; NEUROGLIA; NEURONAL PLASTICITY; PROTEIN-TYROSINE KINASES; SEROTONIN; STIMULATION, CHEMICAL;

EID: 38049085209     PISSN: 13402544     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (64)

1. Airaksinen, M. S. and Saarma, M. (2002) The GDNF family: Signaling biological functions and therapeutic value. Nat Rev Neurosci, 3: 383-394.
2. Åkerud, P., Holm, P. C., Castelo-Branco, G., Sousa, K., Rodriguez, F. J. and Arenas, E. (2002) Persephin-overexpressing neural stem cells regulate the function of nigral dopaminergic neurons and prevent their degeneration in a model of Parkinson's disease. Mol Cell Neurosci, 21: 205-222.
3. Anderson, M. F., Aberg, M. A., Nilsson, M. and Eriksson, P. S. (2002) Insulin-like growth factor-I and neurogenesis is the adult mammalian brain. Brain Res Dev Brain Res, 134: 115-122.
4. Bespalov, M. M. and Saarma, M. (2007) GDNF family receptor complexes are emerging drug targets. Trends Pharmacol Sci, 28: 68-74.
5. Blasko, I., Lederer, W., Oberbauer, H., Walch, T., Kemmler, G., Hinterhuber, H., Marksteiner, J. and Humpel, C. (2006) Measurement of thirteen biological markers in CSF of patients with Alzheimer's disease and other dementias. Dement Geriatr Cogn Disord, 21: 9-15.
6. Cao, L., Jiao, X., Zuzga, D. S., Liu, Y., Fong, D. M., Young, D. and During, M. J. (2004) VEGF links hippocampal activity with neurogenesis, learning and memory. Nat Genet, 36: 827-835.
7. Chebroulu, H., Slevin, J. T., Gash, D. A., Gerhardt, G. A., Young, B., Gicen, C. A. and Smith, C. D. (2006) MRI volumetric and intensity analysis of the cerebellum in Parkinson's disease patients infused with glial-derived neurotrophic factor (GDNF). Exp Neurol, 198: 450-456.
8. Chen, P. S., Peng, G. S., Li, G., Yang, S., Wu, X., Wang, C. C., Wilson, B., Lu, R. B., Gean, P. W., Chuang, D. M. and Hong, J. S. (2006) Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes. Mol Psychiatry, 11: 1116-1125.
9. Chen, Y., Ai, Y., Slevin, J. R., Maley, B. E. and Gash, D. M. (2005) Progenitor proliferation in the adult hippocampus and substantia nigra induced by glial cell line-derived neurotrophic factor. Exp Neurol, 196: 87-95.
10. Chen, Y. H., Harvey, B. K., Hoffman, A. F., Wang, Y., Chiang, Y. H. and Lupica, C. R. (2007) MPTP-induced deficits in striatal synaptic plasticity are prevented by glial cell line-derived neurotrophic factor expressed via an adeno-associated viral vector. FASEB J, in press.
11. Czéh, B., Simon, M., Schmelting, B., Hiemke, C. and Fuchs, E. (2006) Astroglial plasticity in the hippocampus is affected by chronic psychosocial stress and concomitant fluoxetine treatment. Neuropsychopharmacology, 31: 1616-1626.
12. Darlington, C. L. (2005) Astrocytes as targets for neuroprotective drugs. Curr Opin Investig Drugs, 6: 700-703.
13. Duman, R. S. (2004) Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromolecular Med, 5: 11-25.
14. Evans, S. J., Choudary, P. V., Neal, C. R., Li, J. Z., Vawter, M. P., Tomita, H., Lopez, J. F., Thompson, R. C., Meng, F., Stead, J. D., Walsh, D. M., Myers, R. M., Bunney, W. E., Watson, S. J., Jones, E. G. and Akil, H. (2004) Dysregulation of the fibroblast growth factor system in major depression. Proc Natl Acad Sci USA, 101: 15506-15511.
15. Fields, R. D. and Stevens-Graham, B. (2002) New insights into neuron-glia communication. Science, 298: 556-562.
16. Gardell, L. R., Wang, R., Ehrenfels, C., Ossipov, M. H., Rossomando, A. J., Miller, S., Buckley, C., Cai, A. K., Tse, A., Foley, S. F., Gong, B., Walus, L. Carmillo, P., Worley, D., Huang, C., Engber, T., Pepinsky, B., Cate, R. L., Vanderah, T. W., Lai, J., Sah, D. W. and Porreca, F. (2003) Multiple actions of systemic artemin in experimental neuropathy. Nat Med, 9: 1383-1389.
17. Garcès, A., Livet, J., Grillet, N., Henderson, C. E. and Delapeyrière, O. (2001) Responsiveness to neurturin of subpopulations of embryonic rat spinal motoneuron does not correlate with expression of GFR alpha 1 or GFR alpha 2. Dev Dyn, 220: 189-197.
18. Gash, D. M., Zhang, Z., Ovadia, A., Cass, W. A., Yi, A., Simmerman, L., Russell, D., Martin, D., Lapchak, P. A., Collins, F., Hoffer, B. J. and Gerhardt, G. A. (1996) Functional recovery in perkinsonian monkeys treated with GDNF. Nature, 380: 252-255.
19. Gerlai, R., McNamara, A., Choi-Lundberg, D. L., Armanini, M., Ross, J., Powell-Braxton, L. and Phillips, H. S. (2001) Impaired water maze learning performance without altered dopaminergic function in mice heterozygous for the GDNF mutation. Eur J Neurosci, 14: 1153-1163.
20. Gill, S. S., Paterl, N. K., Hotton, G. R., O'Sullivan, K., McCarter, R., Bunnage, M., Brooks, D. J., Svendsen, C. N. and Heywood, P. (2003) Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med, 9: 589-595.
21. Golden, J. P., Baloh, R. H., Kotzbauer, P. T., Lampe, P. A., Osborne, P. A., Milbrandt, J. and Johnson, E. M. (1998) Expression of neurturin, GDNF and their receptors in the adult mouse CNS. J Comp Neurol, 398: 139-150.
22. Golden, J. P., DeMaro, J. A., Osborne, P. A., Milbrandt, J. and Johnson, E. M. (1999) Expression of neurturin, GDNF and GDNF family-receptor mRNA in the developing and mature mouse. Exp Neurol, 158: 504-528.
23. Golden, J. P., Milbrandt, J. and Johnson, E. M. (2003) Neurturin and persephin promote the survival of embryonic basal forebrain cholinergic neurons in vitro. Exp Neurol, 184: 447-455.
24. Grondin, R., Zhang, Z., Yi, A., Cass, W. A., Maswood, N., Andersen, A. H., Elsberry, D. D., Klein, M. C., Gerhardt, G. A. and Gash, D. M. (2002) Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys. Brain, 125: 2191-2201.
25. Hamidi, M., Derevets, W. C. and Price, J. L. (2004) Glial reduction in amygdala in major depressive disorder is due to oligodendrocytes. Biol Psychiatry, 55: 563-569.
26. He, D. Y., McGough, N. N., Ravindranathan, A., Jeanblanc, J., Logrip, M. L., Phamluong, K., Janak, P. H. and Ron, D. (2005) Glial cell line-derived neurotrophic factor mediates the desirable actions of the anti-addiction drug ibogaine against alcohol consumption. J Neurosci, 25: 619-628.
27. Henderson, C. E., Phillips, H. S., Pollock, R. A., Davies, A. M., Lemeulle, C., Armanini, M., Simmons, L., Moffet, B., Vandlen, R. A. and Simpson, L. C. (1994) GDNF: A potent survival factor for motoneurons present in peripheral nerve and muscle. Science, 266: 1062-1064.
28. Hisaoka, K., Nishida, A., Koda, T., Miyata, M., Zensho, H., Morinobu, S., Ohta, M. and Yamawaki, S. (2001) Antidepressant drug treatments induce glial cell line-derived neurotrophic factor (GDNF) synthesis and release in rat C6 glioblastoma cells. J Neurochem, 79: 25-34.
29. Hisaoka, K., Nishida, A., Takebayashi, M., Koda, T., Yamawaki, S. and Nakata, Y. (2004) Serotonin increases glial cell line-derived neurotrophic factor release in C6 glioblastoma cells. Brain Res, 1002: 167-170.
30. Hisaoka, K., Takebayashi, M., Tsuchioka, M., Maeda, N., Nakata, Y. and Yamawaki, S. (2007) Antidepressants increase glial cell line-derived neurotrophic factor production through monoamine-independent activation of protein tyrosine kinase and extracellular signal-regulated kinase in glial cells. J Pharmacol Exp Ther, 321: 148-157.
31. Kawano, K., Morinobu, S., Sawada, T., Tsuji, S., Hisaoka, K., Takebayashi, M., Kozuru, T. and Yamawaki, S. Neonatal isolation reduces induction of NGF mRNA and decreases GDNF mRNA in the hippocampus of rodents subsequently subjected to immobilization stress during adulthood. Synapse, in press.
32. Kitagawa, H., Hayashi, T., Mitsumoto, Y., Koga, N., Itoyama, Y. and Abe, K. (1998) Reduction of ischemic brain injury by topical application of glial cell line-derived neurotrophic factor after permanent middle cerebral artery occlusion in rat. Stroke, 29: 1417-1422.
33. Kobayashi, T., Ahlenius, H., Thored, P., Kobayashi, R., Kokaia, Z. and Lindvall, O. (2006) Intracerebral infusion of glial cell line-derived neurotrophic factor promotes striatal neurogenesis after stroke in adult rats. Stroke, 37: 2361-2367.
34. Kordower, J. H., Emborg, M. E., Bloch, J., Ma, S. Y., Chu, Y., Leventhal, L., McBride, J., Chan, E. Y., Palfi, S., Roitberg, B. Z., Brown, W. D., Holden, J. E., Pyzalski, R., Taylor, M. D., Carvey, P., Ling, Z., Trono, D., Hantraye, P., Deglon, N. and Aebischer, P. (2000) Neurodegenearation prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science, 290: 767-773.
35. Lang, A. E., Gill, S., Patel, N. K., Lozano, A., Nutt, J. G., Penn, R., Brooks, D. J., Hotton, G., Moro, E., Heywood, P., Brodsky, M. A., Burchiel, K., Kelly, P., Dalvi, A., Scott, B., Stacy, M., Turner, D., Wooten, V. G., Elias, W. J., Laws, E. R., Dhawan, V., Stoessl, A. J., Matcham, J., Coffey, R. J. and Traub, M. (2006) Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease. Ann Neurol, 59: 459-466.
36. Ledda, F., Paratcha, G., Sandoval-Guzmán, T. and Ibáñez, C. F. (2007) GDNF and GFRα1 promote formation of neuronal synapses by ligand-induced cell adhesion. Nat Neurosci, 10: 293-300.
37. Li, L., Wu, W., Lin, L. F. Lei, M., Oppenheim, R. W. and Houenou, L. J. (1995) Rescue of adult mouse motoneurons from injury-induced cell death by glial cell line-derived neurotrophic factor. Proc Natl Acad Sci USA, 92: 9771-9775.
38. Lin, L. F., Doherty, D. H., Lile, J. D., Bektesh, S. and Collins, F. (1993) GDNF: A glial cell line-derived neruotrophic factor for midbrain dopaminergic neurons. Science, 260: 1130-1132.
39. Love, S., Plaha, P., Patel, N. K., Hotton, G. R., Brooks, D. J. and Gill, S. S. (2005) Glial cell line-derived neurotrophic factor induces neuronal sprouting in human brain. Nat Med, 11: 703-704.
40. Mallei, A., Shi, B. and Mocchetti, I. (2002) Antidepressant treatment induce the expression of basic fibroblast growth factor in cortical and hippocampal neurons. Mol Pharmacol, 61: 1017-1024.
41. McBride, J. L., Ramaswamy, S., Gasmi, M., Bartus, R. T., Herzog, C. D., Barndon, E. P., Zhou, L., Pitzer, M. R., Berry-Kravis, E. M. and Kordower, J. H. (2006) Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease. Proc Natl Acad Sci USA, 103: 9345-9350.
42. Mercier, G., Lennon, A. M., Renouf, B., Dessouroux, A., Ramaguè, M., Courtin, F. and Pierre, M. (2004) MAP kinase activation by fluoxetine and its relation to gene expression in cultured rat astrocytes. J Mol Neurosci, 24: 207-216.
43. Messer, C. J., Eisch, A. J., Carlezon, W. A. Whisler, K., Shen, L., Wolf, D. H., Westphal, H., Collins, F., Russell, D. S. and Nestler, E. J. (2000) Role for GDNF in biochemical and behavioral adaptations to drugs of abuse. Neuron, 26: 247-257.
44. Nibuya, M. Morinobu, S. and Duman, R. S. (1995) Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatment. J Neurosci, 15: 7539-7547.
45. Niwa, M., Nitta, A., Yamada, Y., Nakajima, A., Saito, K., Seishima, M., Shen, L., Noda, Y., Furukawa, S. and Nabeshima, T. (2007) An inducer for glial cell line-derived neurotrophic factor and tumor necrosis factor-alpha protects against methamphetamine-induced rewarding effects and sensitization. Biol Psychiatry, 61: 890-901.
46. Öngür, D., Drevets, C. W. and Price, J. L. (1998) Glial reduction in the subgenual prefrontal cortex in mood disosrders. Proc Natl Acad Sci USA, 95: 13290-13295.
47. Paratcha, G., Ledda, F. and Ibáñrz, C. F. (2003) The neural cell adhesion molecule NCAM is an alternative signaling receptor for GDNF family ligands. Cell, 113: 867-879.
48. Patel, N. K., Bunnage, M., Plaha, P., Svendsen, C. N., Heywood, P. and Gill, S. S. (2005) Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD: A two-year outcome study. Ann Neurol, 57: 298-302.
49. Pertusa, M., Matas-García, S., Mammen, H., Adell, A., Rodrigo, T., Mallet, J., Cristòfol, R., Sarkis, C. and Sanfeliu, C. (2007) Expression of GDNF transgene in astrocytes improves cognitive deficits in aged rats. Neurobiol Aging, in press.
50. Rajkowska, G., Miguel-Hidalgo, J. J., Wei, J., Dilley, G., Pittman, S. D., Meltzer, H. Y., Overholser, J. C., Roth, B. L. and Stockmeier, C. A. (1999) Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry, 45: 1085-1098.
51. Rosa, A. R., Frey, B. N., Andrezza, A. C., Cresér, K. M., Cunha, A. B. M., Quevedo, J., Santin, A., Gottfried, C., Gonçalves, C. A., Vieta, E. and Kapczinski, F. (2006) Increased serum glial cell line-derived neurotrophic factor immunocontent during manic and depressive episodes in individuals with bipolar disorder. Neurosci Lett, 407: 146-150.
52. Saarma, M. and Sariola, H. (1999) Other neurotrophic factors: Glial cell line-derived neurotrophic factor (GDNF). Microsc Res Tech, 45: 292-302.
53. Sagot, Y., Tan, S. A., Hammang, J. P., Aebischer, P. and Kato, A. C. (1996) GDNF slows loss of motoneurons but not axonal degeneration or premature death of pmn/pmn mice. J Neurosci, 16: 2335-2341.
54. Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., Belzung, C. and Hen, R. (2003) Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science, 301: 805-809.
55. Schaar, D. G., Sieber, B. A., Dreyfus, C. F. and Black, I. B. (1993) Regional and cell-specific expression of GDNF in rat brain. Exp Neurol, 124: 368-371.
56. Si, X., Hidalgo-Miguel, J. J., O'Dwyer, G., Stockmeier, C. A. and Rajkowska, G. (2004) Age dependent reductions in the level of glial fibrillary acidic protein in the prefrontal cortex in major depression. Neuropsychopharmacology, 9: 2088-2096.
57. Slevin, J. T., Gerhardt, G. A., Smith, C. D., Gash, D. M., Kryscio, R. and Young, B. (2005) Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor. J Neurosurg, 102: 216-222.
58. Takebayashi, M., Hisaoka, K., Nishida, A., Tsuchioka, M., Miyoshi, I., Kozuru, T., Hikasa, S., Okamoto, Y., Shinno, H., Morinobu, S. and Yamawaki, S. (2006) Decreased levels of whole blood glial cell line-derived neurotrophic factor (GDNF) in remitted patients with mood disorders. Int J Neuropsychopharmacol, 9: 607-612.
59. Tomac, A. C., Agulnick, A. D., Haughey, N., Chang, C. F., Zhang, Y., Bäckman, C., Morales, M., Mattson, M. P., Wang, Y., Westphal, H., Hoffer, B. J. (2002) Effects of cerebral ischemia in mice deficient in Persephin. Proc Natl Acad Sci USA, 99: 9521-9526.
60. Warner-Schmidt, J. L. and Duman, R. S. (2007) VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressant. Proc Natl Acad Sci USA, 104: 4647-4652.
61. Yan, Y., Yamada, K., Niwa, M., Nagai, T., Nitta, A. and Nabeshima, T. (2007) Enduring vulnerability to reinstatement of methamphetamine-seeking behavior in glial cell line-derived neurotrophic factor mutant mice. FASEB J, 21: 1994-2004.
62. Ye, M., Wang, X. J., Zhang, Y. H., Lu, G. Q., Liang, L., Xu, J. Y. and Chen, S. D. (2007) Transplantation of bone marrow stromal cells containing the neurturin gene in rat model of Parkinson's disease. Brain Res, 1142: 206-216.
63. Yoshimura, S., Takagi, Y., Harada, J., Teramoto, T., Thomas, S. S., Waeber, C., Bakowska, J. C., Breakefield, X. O. and Moskowitz, M. A. (2001) FGF-2 regulation of neurogenesis in adult hippocampus after brain injury. Proc Natl Acad Sci USA, 98: 5874-5879.
64. Young, D., Lawlor, P. A., Leone, P., Dragunow, M. and During, M. J. (1999) Environmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective. Nat Med, 5: 448-453.